The UK life sciences and pharmaceutical industry needs to invest in automation and digitisation to combat rising costs and remain competitive.
To continue reading, you must be a paying member of the Institution. Log in now and enjoy full access to expert commentary and features from Professional Engineering magazine
Log in to My Account
Or find out how to become a member of the Institution
Become a member
Read more related articles